DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 159 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q2 2018. The put-call ratio across all filers is 0.83 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $506,464 | -16.0% | 47,600 | -17.6% | 0.00% | -20.0% |
| Q3 2022 | $603,000 | +59.9% | 57,750 | +65.9% | 0.01% | +66.7% |
| Q1 2022 | $377,000 | +55.1% | 34,800 | +101.2% | 0.00% | +50.0% |
| Q4 2021 | $243,000 | -33.8% | 17,300 | -79.6% | 0.00% | -71.4% |
| Q3 2020 | $367,000 | -49.9% | 84,834 | +76.4% | 0.01% | -82.5% |
| Q2 2018 | $733,000 | +40.4% | 48,100 | +82.8% | 0.04% | +2.6% |
| Q1 2018 | $522,000 | +13.0% | 26,308 | +6.5% | 0.04% | +2.6% |
| Q4 2017 | $462,000 | +158.1% | 24,699 | +44.7% | 0.04% | +26.7% |
| Q3 2016 | $179,000 | – | 17,070 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 8,415,000 | $105,945,000 | 12.42% |
| Chicago Capital, LLC | 5,842,906 | $73,562,000 | 4.06% |
| PFM Health Sciences, LP | 3,805,370 | $47,910,000 | 1.83% |
| Rhenman & Partners Asset Management AB | 800,000 | $10,072,000 | 1.14% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 2,320,000 | $29,209,000 | 0.71% |
| Rock Springs Capital Management LP | 1,681,458 | $21,170,000 | 0.62% |
| FEDERATED HERMES, INC. | 16,022,731 | $201,726,000 | 0.55% |
| FIRETHORN WEALTH PARTNERS, LLC | 47,376 | $665,000 | 0.54% |
| Jackson Creek Investment Advisors LLC | 82,435 | $1,185,000 | 0.48% |
| OBERWEIS ASSET MANAGEMENT INC/ | 137,200 | $1,727,000 | 0.44% |